Lo Farma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Lo Farma
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€5,464
2024 · €76,764-€71,300
Equity
€285,959
2024 · €280,496+€5,464
Cash
€55,969
2024 · €99,465-€43,497
Balance sheet total
€875,320
2024 · €959,323-€84,003
Largest movements
Assets
- Cash -€43,497
down €43,497 (-43.7%), from €99,465 to €55,969
mainly Debts after one year (-€63,000) and Other debts (-€32,500)
- Tangible fixed assets -€36,843
down €36,843 (-5.3%), from €692,984 to €656,141
of which Land and buildings: -€33,025
Equity and liabilities
- Debts after one year -€63,000
down €63,000 (-15.1%), from €418,585 to €355,585
- Other debts -€32,500
down €32,500 (-36.6%), from €88,896 to €56,396
Income statement
- Staff costs +€39,163
up €39,163 (+49.9%), from €78,451 to €117,614
- Gross operating margin -€34,816
down €34,816 (-15.7%), from €222,210 to €187,394
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€76,764
Gross operating margin
-€34,816
Staff costs
-€39,163
Depreciation
+€370
Other operating charges
-€95
Financial income
+€1,126
Financial charges
+€1,278
Taxes
+€0
Result 2025
€5,464
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€30,066
Investment
-€10,563
Financing
-€63,000
Cash 2024
€99,465
From operations (derived)
+€30,066
Net result for the year
+€5,464
Depreciation
+€52,406
Stocks and contracts
-€319
Receivables within one year
-€3,861
Deferred charges and accrued income
+€2,843
Trade debts
+€2,974
Tax, wage and social debts
-€2,516
Other debts
-€32,500
Accrued charges and deferred income
+€5,575
Investment (derived)
-€10,563
Investment in fixed assets (net)
-€15,563
Current investments
+€5,000
Financing
-€63,000
Debts after one year
-€63,000
Cash 2025
€55,969
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €959,323 | €875,320 | -€84,003 | -8.8% |
| Fixed assets | 21/28 | €692,984 | €656,141 | -€36,843 | -5.3% |
| Tangible fixed assets | 22/27 | €692,984 | €656,141 | -€36,843 | -5.3% |
| Land and buildings | 22 | €658,807 | €625,783 | -€33,025 | -5.0% |
| Plant, machinery and equipment | 23 | €34,177 | €24,693 | -€9,484 | -27.7% |
| Furniture and vehicles | 24 | - | €5,665 | +€5,665 | |
| Current assets | 29/58 | €266,339 | €219,179 | -€47,160 | -17.7% |
| Stocks and contracts in progress | 3 | €99,857 | €100,176 | +€319 | +0.3% |
| Stocks | 30/36 | €99,857 | €100,176 | +€319 | +0.3% |
| Amounts receivable within one year | 40/41 | €4,856 | €8,717 | +€3,861 | +79.5% |
| Trade receivables | 40 | €4,834 | €6,977 | +€2,143 | +44.3% |
| Other amounts receivable | 41 | €22 | €1,740 | +€1,718 | +7,791% |
| Current investments | 50/53 | €5,000 | - | -€5,000 | |
| Cash at bank and in hand | 54/58 | €99,465 | €55,969 | -€43,497 | -43.7% |
| Deferred charges and accrued income | 490/1 | €57,161 | €54,317 | -€2,843 | -5.0% |
| Total equity and liabilities | 10/49 | €959,323 | €875,320 | -€84,003 | -8.8% |
| Equity | 10/15 | €280,496 | €285,959 | +€5,464 | +1.9% |
| Contributions | 10/11 | €558,000 | €558,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€277,504 | -€272,041 | +€5,464 | +2.0% |
| Amounts payable | 17/49 | €678,827 | €589,361 | -€89,467 | -13.2% |
| Amounts payable after more than one year | 17 | €418,585 | €355,585 | -€63,000 | -15.1% |
| Financial debts | 170/4 | €418,585 | €355,585 | -€63,000 | -15.1% |
| Amounts payable within one year | 42/48 | €259,294 | €227,253 | -€32,042 | -12.4% |
| Current portion of amounts payable after more than one year | 42 | €63,000 | €63,000 | = | 0.0% |
| Trade debts | 44 | €102,394 | €105,368 | +€2,974 | +2.9% |
| Suppliers | 440/4 | €102,394 | €105,368 | +€2,974 | +2.9% |
| Taxes, remuneration and social security | 45 | €5,004 | €2,488 | -€2,516 | -50.3% |
| Taxes | 450/3 | €4,132 | €1,576 | -€2,556 | -61.9% |
| Remuneration and social security | 454/9 | €872 | €913 | +€41 | +4.7% |
| Other amounts payable | 47/48 | €88,896 | €56,396 | -€32,500 | -36.6% |
| Accrued charges and deferred income | 492/3 | €948 | €6,523 | +€5,575 | +588% |
| Remuneration, social security and pensions | 62 | €78,451 | €117,614 | +€39,163 | +49.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €52,776 | €52,406 | -€370 | -0.7% |
| Other operating charges | 640/8 | €1,705 | €1,800 | +€95 | +5.6% |
| Gross operating margin | 9900 | €222,210 | €187,394 | -€34,816 | -15.7% |
| Operating profit (loss) | 9901 | €89,277 | €15,573 | -€73,704 | -82.6% |
| Financial income | 75/76B | €353 | €1,479 | +€1,126 | +319% |
| Recurring financial income | 75 | €353 | €1,479 | +€1,126 | +319% |
| Financial charges | 65/66B | €12,866 | €11,589 | -€1,278 | -9.9% |
| Recurring financial charges | 65 | €12,866 | €11,589 | -€1,278 | -9.9% |
| Profit (loss) for the period before taxes | 9903 | €76,764 | €5,464 | -€71,300 | -92.9% |
| Income taxes | 67/77 | €0 | - | -€0 | |
| Profit (loss) for the period | 9904 | €76,764 | €5,464 | -€71,300 | -92.9% |
| Profit (loss) for the period to be appropriated | 9905 | €76,764 | €5,464 | -€71,300 | -92.9% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.